EA201190243A1 - STABLE PHARMACEUTICAL COMPOSITION OF FLUDARABIN PHOSPHATE - Google Patents

STABLE PHARMACEUTICAL COMPOSITION OF FLUDARABIN PHOSPHATE

Info

Publication number
EA201190243A1
EA201190243A1 EA201190243A EA201190243A EA201190243A1 EA 201190243 A1 EA201190243 A1 EA 201190243A1 EA 201190243 A EA201190243 A EA 201190243A EA 201190243 A EA201190243 A EA 201190243A EA 201190243 A1 EA201190243 A1 EA 201190243A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
stable pharmaceutical
fludarabin phosphate
phosphate
fludarabin
Prior art date
Application number
EA201190243A
Other languages
Russian (ru)
Inventor
Ивета Дэнс
Original Assignee
Гриндекс, Э Джоинт Сток Кампани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Гриндекс, Э Джоинт Сток Кампани filed Critical Гриндекс, Э Джоинт Сток Кампани
Publication of EA201190243A1 publication Critical patent/EA201190243A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Abstract

Стабильная фармацевтическая композиция, содержащая флударабина фосфат в качестве активного ингредиента.Stable pharmaceutical composition containing fludarabina phosphate as an active ingredient.

EA201190243A 2009-05-19 2010-05-19 STABLE PHARMACEUTICAL COMPOSITION OF FLUDARABIN PHOSPHATE EA201190243A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09160620 2009-05-19
PCT/EP2010/056878 WO2010133629A1 (en) 2009-05-19 2010-05-19 Stable pharmaceutical composition of fludarabine phosphate

Publications (1)

Publication Number Publication Date
EA201190243A1 true EA201190243A1 (en) 2013-01-30

Family

ID=40846159

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201190243A EA201190243A1 (en) 2009-05-19 2010-05-19 STABLE PHARMACEUTICAL COMPOSITION OF FLUDARABIN PHOSPHATE

Country Status (3)

Country Link
EP (1) EP2432457A1 (en)
EA (1) EA201190243A1 (en)
WO (1) WO2010133629A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102525996A (en) * 2012-03-15 2012-07-04 山东新时代药业有限公司 Capsules containing fludarabine phosphate and preparation method for capsules

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174873B1 (en) * 1998-11-04 2001-01-16 Supergen, Inc. Oral administration of adenosine analogs
CZ20002567A3 (en) * 2000-07-11 2001-12-12 Léčiva, A.S. Tablet that can be prepared by direct tabletting containing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active substance and process for preparing thereof
DE10164510A1 (en) * 2001-12-20 2003-07-10 Schering Ag Oral Fludara pure formulation with rapid release of the active ingredient
ES2412879T3 (en) * 2005-11-11 2013-07-12 Boehringer Ingelheim International Gmbh Combined cancer treatment comprising EGFR / HER2 inhibitors

Also Published As

Publication number Publication date
WO2010133629A1 (en) 2010-11-25
EP2432457A1 (en) 2012-03-28

Similar Documents

Publication Publication Date Title
CY1121843T1 (en) MAGNESIUM ION STABILIZED RECEPTOR FORMULATIONS
EA201300146A1 (en) PHARMACEUTICAL COMPOSITIONS OF C-MET MODULATOR
BRPI0917017B8 (en) s-nitrosoglutathione reductase pyrrole inhibitors as therapeutic agents
AR081681A1 (en) METHODS AND COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF b-GALACTOCEREBROSIDASA
EA201270216A1 (en) PHARMACEUTICAL COMPOSITION
EA201590805A1 (en) COMPOSITION WITH IMMEDIATE AND PROLONGED DELIVERY
MX2013001677A (en) Stable formulations of linaclotide.
PH12014502462A1 (en) Complement pathway modulators and uses thereof
EA201270590A1 (en) ACTIVE INHIBITORS
EA201270741A1 (en) ORAL COMPOSITIONS AND LIPOPHYL SALTS OF METHylNALTREX
MX341200B (en) A fast dissolving pharmaceutical composition.
EA201101116A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING 2-OXO-1-PYRROLIDINE DERIVATIVES
EA201101118A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING 2-OXO-1-PYRROLIDINE DERIVATIVES
EA201291211A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING HYDROMORPHONE AND NALOXONE
EA201200616A1 (en) DERIVATIVES 2-OXO-1-PIRROLIDININILIMIDAZOTHIAADIA ASOL
MX2014001368A (en) Stable anti-inflammatory solutions for injection.
MX2016001422A (en) Pharmaceutical compositions of fingolimod.
EA201300857A1 (en) PYRAZOLES AS AN ANTAGONISTS CRTH2
TR200909785A1 (en) Pharmaceutical compositions containing cefdinir as the active agent.
CL2012001759A1 (en) 8-hydroxyquinoline-7-carboxamide derived compounds; pharmaceutical composition.
EA201400444A1 (en) DERIVATIVES 2-OXOPYPERIDINYL
EA201190243A1 (en) STABLE PHARMACEUTICAL COMPOSITION OF FLUDARABIN PHOSPHATE
TR201010859A2 (en) Tablet forms containing cefdinir.
TR201009166A2 (en) Production method for cefdinir-containing pharmaceutical composition
TR201009399A2 (en) Rapidly soluble effervescent rosuvastatin formulations.